DOXOrubicin

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 92911 publications

Targeted therapy of highly aggressive thyroid papillary carcinoma by AS1411-guided nanomaterials.

Targeted therapy of highly aggressive thyroid papillary carcinoma by AS1411-guided nanomaterials.

Journal: Nanomedicine (London, England)
Published: June 23, 2026

Wax-printing-free fabrication of paper-supported 3D cancer cell culture.

Wax-printing-free fabrication of paper-supported 3D cancer cell culture.

Journal: Analytical methods : advancing methods and applications
Published: June 23, 2026

NINJ1 Aggravates Doxorubicin-Induced Cardiotoxicity by Suppressing AMPK-Mediated HIF-1α Deubiquitination.

NINJ1 Aggravates Doxorubicin-Induced Cardiotoxicity by Suppressing AMPK-Mediated HIF-1α Deubiquitination.

Journal: Antioxidants & redox signaling
Published: June 23, 2026

Single-agent gemcitabine enabling successful bridging to allogeneic haematopoietic stem-cell transplantation in refractory peripheral T-cell lymphoma, not otherwise specified.

Single-agent gemcitabine enabling successful bridging to allogeneic haematopoietic stem-cell transplantation in refractory peripheral T-cell lymphoma, not otherwise specified.

Journal: BMJ case reports
Published: June 23, 2026

Hodgkin lymphoma treatment patterns and outcome disparities in low- and middle-income countries.

Hodgkin lymphoma treatment patterns and outcome disparities in low- and middle-income countries.

Journal: Blood global hematology
Published: June 19, 2026

Diffuse large B-cell lymphoma masquerading as multiple myeloma.

Diffuse large B-cell lymphoma masquerading as multiple myeloma.

Journal: BMJ case reports
Published: June 19, 2026

Spurious Plasma Adrenocorticotropic Hormone Level in a Patient With Adrenal Cushing Syndrome.

Spurious Plasma Adrenocorticotropic Hormone Level in a Patient With Adrenal Cushing Syndrome.

Journal: Ochsner journal
Published: June 18, 2026

Multi-Omics Analysis Identifies Paxillin as a Biomarker of Doxorubicin Resistance via Cytoskeletal Remodeling and Immune Exhaustion.

Multi-Omics Analysis Identifies Paxillin as a Biomarker of Doxorubicin Resistance via Cytoskeletal Remodeling and Immune Exhaustion.

Journal: Journal of proteome research
Published: June 18, 2026

Co-Delivery of Chemo and Immune Drugs by Prussian Blue Nanocubes for Combinational Therapy and T1-T2W MR Imaging of MDA-MB-231.

Co-Delivery of Chemo and Immune Drugs by Prussian Blue Nanocubes for Combinational Therapy and T1-T2W MR Imaging of MDA-MB-231.

Journal: ACS applied bio materials
Published: June 16, 2026

An intelligent responsive nanoplatform based on a DNA nanoflowers/Mn:CuS hybrid for targeted and synergistic cancer therapy.

An intelligent responsive nanoplatform based on a DNA nanoflowers/Mn:CuS hybrid for targeted and synergistic cancer therapy.

Journal: Journal of materials chemistry. B
Published: June 16, 2026

Aromatic/aliphatic residue balance regulates Cu(II)-induced supramolecular gel formation and drug release in histidine-containing tetrapeptides.

Aromatic/aliphatic residue balance regulates Cu(II)-induced supramolecular gel formation and drug release in histidine-containing tetrapeptides.

Journal: Soft matter
Published: June 16, 2026

Ensemble and single particle analysis of doxorubicin silk nanoparticles.

Ensemble and single particle analysis of doxorubicin silk nanoparticles.

Journal: Chemical communications (Cambridge, England)
Published: June 16, 2026
Showing 1-12 of 92,911

Last Updated: 06/30/2026